{"organizations": [], "uuid": "a37015de21b690c7e1c630662195fff0c9b6d4e8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://si.wsj.net/public/resources/images/BN-XO195_3gXuG_TOP_20180220181625.jpg", "site_section": "https://www.wsj.com/news/markets", "section_title": "Stock Market &amp; Finance News - Wall Street Journal", "url": "https://www.wsj.com/articles/deal-making-just-got-tougher-for-struggling-generic-drugmakers-1519209002", "country": "US", "domain_rank": 387, "title": "Deal Making Just Got Tougher for Struggling Generic Drugmakers", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.898, "site_type": "news", "published": "2018-02-21T13:30:00.000+02:00", "replies_count": 0, "uuid": "a37015de21b690c7e1c630662195fff0c9b6d4e8"}, "author": "Charley Grant", "url": "https://www.wsj.com/articles/deal-making-just-got-tougher-for-struggling-generic-drugmakers-1519209002", "ord_in_thread": 0, "title": "Deal Making Just Got Tougher for Struggling Generic Drugmakers", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Merger mania has gripped health care. The generic drugs sector might have trouble joining the party.\nGeneric drugmakers are being squeezed from both sides. Prices are falling because the companies that buy the drugs have consolidated, putting the relatively fragmented drugmakers at a disadvantage. And, the Food and Drug Administration has sped up approvals for new generic drugs, adding new competition to the market.\nMergers... ", "external_links": [], "published": "2018-02-21T13:30:00.000+02:00", "crawled": "2018-02-21T14:08:27.001+02:00", "highlightTitle": ""}